Simulations (Ep. 27)

This episode discusses simulations. I group simulations into 4 categories: (1) average response, (2) population, (3) individual, and (4) clinical trial simulations. I discuss details of each of these types of simulations and the different variability terms included in each one. I strongly recommend that we implement more clinical trial simulations in our work. This will help us design and execute more successful clinical trials that take advantage of our existing knowledge about a drug. Enjoy the show and connect with me using the links below if you have any questions.


Links discussed in the show:


Copyright Teuscher Solutions LLC

All Rights Reserved

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(57)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)

In this episode I discuss bioequivalence testing and how it was developed to support generic drug approvals, but is now a mainstream tool for all of drug development. I discuss the basics of what bioe...

25 Mai 24min

Examining Volume of Distribution (Ep. 56)

Examining Volume of Distribution (Ep. 56)

In this episode we’re going to define Volume of Distribution, look at the different types of Volume of Distribution parameters, talk about how we actually calculate it, examine what drives its value, ...

20 Apr 19min

Talking about data science with Mike Stackhouse (Ep. 55)

Talking about data science with Mike Stackhouse (Ep. 55)

This episode is an interview with Michael Stackhouse, the Chief Innovation Officer at Atorus Research. We discussed a variety of topics such as modern data science tools, why regulatory agencies want ...

16 Mar 45min

Using Accelerator Mass Spectrometry in Clinical Pharmacology

Using Accelerator Mass Spectrometry in Clinical Pharmacology

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism ...

16 Feb 38min

Using AI tools for regulatory intelligence (Ep. 53)

Using AI tools for regulatory intelligence (Ep. 53)

This episode is an interview with Aruna Dhontabhaktuni, Founder and CEO of RegKey, a regulatory intelligence platform that uses AI. The discussion touches on how companies can leverage large language ...

19 Jan 21min

When to use model-informed drug development (Ep. 52)

When to use model-informed drug development (Ep. 52)

This episode is a collection of my thoughts on model-informed drug development and where different modeling modalities fit into the development schedule. These are just my opinions and each developmen...

22 Des 202528min

QSP Modeling with Ahmed Elmokadem (Ep. 51)

QSP Modeling with Ahmed Elmokadem (Ep. 51)

In this episode I chat with Ahmed Elmokadem about QSP modeling. Ahmed, from Metrum Research Group, is an expert consultant in QSP modeling and how it can be used to provide a framework to connect mech...

24 Nov 202544min

CDISC datasets and ACoP 2025 (Ep. 50)

CDISC datasets and ACoP 2025 (Ep. 50)

In this episode I discuss dataset-JSON, a new proposed data standard for CDISC files and explain some of the CDISC files I use in my clinical pharmacology work. I end with some brief thoughts about th...

27 Okt 202518min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
sinnsyn
vett-og-vitenskap-med-gaute-einevoll
rekommandert
liberal-halvtime
dekodet-2
villmarksliv
rss-nysgjerrige-norge
rss-inn-til-kjernen-med-sunniva-rose
diagnose
rss-rekommandert
fjellsportpodden
rss-overskuddsliv
nevropodden
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
rss-paradigmepodden
smart-forklart